Profil
Michael Hamill is currently an Origination Partner at Flagship Pioneering, Inc. since 2025.
Formerly, Dr. Hamill was Vice President-Research at Axcella Health, Inc. from 2011 to 2021.
Dr. Hamill earned a doctorate from Boston University and completed undergraduate degrees at Gettysburg College.
Aktiva positioner av Michael Hamill
| Företag | Position | Start |
|---|---|---|
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Privat kapitalinvesterare | 2021-07-01 |
Tidigare kända positioner av Michael Hamill
| Företag | Position | Slut |
|---|---|---|
| AXCA HEALPAR | Företagsledare/Principal | 2021-06-01 |
Michael Hamills utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
Gettysburg College
Gettysburg College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Axcella Health, Inc.
Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
















